跳至主要内容
临床试验/NCT03377998
NCT03377998Unknown不适用

Expression of Erythroid Differentiation Regulator 1 (Erdr1) Cytokine in the Vitiliginous Skin Lesions: a Case Control Study

Cairo University0 个研究点目标入组 100 人开始时间: 2018年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
100
主要终点
Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo

研究概览

简要总结

Expression of Erythroid differentiation regulator 1 (Erdr1) cytokine in vitiligo

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients with generalized non-segmental vitiligo.
  • •Both sexes.
  • •Age >18 years old.
  • •New cases or cases not receiving any medication for at least 3 months ago.

排除标准

  • •Segmental or Universal vitiligo
  • •Autoimmune diseases

研究组 & 干预措施

vitiligo patients

Experimental

lesional skin biopsy to measure ERDR1 level

干预措施: skin biopsy (Other)

controls

Experimental

normal skin biopsy to measure ERDR1 level

干预措施: skin biopsy (Other)

结局指标

主要结局

Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo

时间窗: 6 months

Expression of tissue levels of erythroid differentiation regulator 1 (Erdr1) cytokine in patients of vitiligo and comparing its level in normal subjects

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maha Fathy Elmasry

principal investigator

Cairo University

相似试验

Expression of Erythroid Differentiation Regulator 1... | 临床试验